Results 81 to 90 of about 2,709 (190)
Fonsecaea pedrosoi is the main etiological agent of chromoblastomycosis, a recalcitrant disease that is extremely difficult to treat. Therefore, new chemotherapeutics to combat this fungal infection are urgently needed.
Vanila F. Palmeira +11 more
doaj +1 more source
Pigmented fungus as a cause of chronic otitis externa: A rare case report
A sporadic infection by a pigmented fungus called chromoblastomycosis is seen in tropical and subtropical climates. It can affect lower extremities most commonly followed by upper extremities.
Pankti Macwan +3 more
doaj +1 more source
Suzanne Alexander, G C Wells
openaire +2 more sources
Photodynamic therapy combined with antifungal drugs for 5 cases of chromoblastomycosis.
Photodynamic therapy combined with antifungal drugs for 5 cases of chromoblastomycosis.
Hengbiao Sun (6991619) +10 more
core +1 more source
A case report on role of surgery in a case of difficult chromoblastomycosis
Chromoblastomycosis is a chronic fungal infection of the skin and subcutaneous tissue caused by dematiaceous fungi. It is most commonly reported in tropical and subtropical rural areas, often affecting farmers due to their increased risk of traumatic ...
S Asiya Begum, Nafees Sultana
doaj +1 more source
An experimental model of murine chromoblastomycosis and in vitro tests with Fonsecaea pedrosoi were used to test the sensitivity of this fungus to three different antimycotics.
Nora Cardona-Castro +2 more
doaj +1 more source
Chromoblastomycosis caused by Cladophialophora carrionii in a child from India
Chromoblastomycosis is a chronic fungal infection of the skin and subcutaneous tissue. It usually occurs following trauma with vegetative matter and mainly affects middle-aged male agricultural workers.
Noyal Mariya Joseph +1 more
core +1 more source
Chromoblastomycosis due to Cladosporium carrionii
An 81-year-old male presented with irregular verrucous growth of 6 years duration over the right leg. KOH preparation of the scrapings and histopathology of the lesion showed “sclerotic” bodies diagnostic of chromoblastomycosis.
Ravi Rathod +3 more
core +1 more source
Chromoblastomycosis: tissue modifications during itraconazole treatment
: Background: Histological and mycological changes during itraconazole use have not been totally established in chromoblastomycosis. Objectives: To evaluate tissue modifications in chromoblastomycosis carriers under itraconazole treatment.
Marcia Olandoski +11 more
core +1 more source

